Free Trial

Barclays PLC Has $5.95 Million Stock Holdings in Healthcare Realty Trust Incorporated (NYSE:HR)

Healthcare Realty Trust logo with Finance background

Barclays PLC cut its stake in shares of Healthcare Realty Trust Incorporated (NYSE:HR - Free Report) by 51.4% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 351,364 shares of the real estate investment trust's stock after selling 371,218 shares during the period. Barclays PLC owned about 0.10% of Healthcare Realty Trust worth $5,954,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the stock. Norges Bank bought a new stake in shares of Healthcare Realty Trust in the 4th quarter valued at approximately $76,825,000. Candriam S.C.A. increased its stake in shares of Healthcare Realty Trust by 201.4% during the 4th quarter. Candriam S.C.A. now owns 1,729,651 shares of the real estate investment trust's stock worth $29,318,000 after purchasing an additional 1,155,745 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. raised its holdings in shares of Healthcare Realty Trust by 289.5% during the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,552,109 shares of the real estate investment trust's stock valued at $26,308,000 after purchasing an additional 1,153,657 shares in the last quarter. Aew Capital Management L P lifted its stake in shares of Healthcare Realty Trust by 1,582.3% in the 4th quarter. Aew Capital Management L P now owns 920,560 shares of the real estate investment trust's stock valued at $15,603,000 after purchasing an additional 865,840 shares during the last quarter. Finally, Russell Investments Group Ltd. boosted its holdings in Healthcare Realty Trust by 22.4% in the fourth quarter. Russell Investments Group Ltd. now owns 2,772,522 shares of the real estate investment trust's stock worth $46,993,000 after purchasing an additional 508,045 shares in the last quarter.

Analyst Ratings Changes

A number of brokerages have weighed in on HR. Jefferies Financial Group cut Healthcare Realty Trust from a "buy" rating to a "hold" rating and reduced their price target for the stock from $19.00 to $17.00 in a research report on Thursday, January 2nd. Wells Fargo & Company decreased their target price on Healthcare Realty Trust from $17.00 to $16.00 and set an "underweight" rating for the company in a research report on Monday, March 10th. Scotiabank dropped their price target on shares of Healthcare Realty Trust from $18.00 to $17.00 and set a "sector perform" rating on the stock in a research report on Tuesday, February 25th. Wedbush raised shares of Healthcare Realty Trust from a "strong sell" rating to a "hold" rating in a report on Monday, April 7th. Finally, StockNews.com lowered shares of Healthcare Realty Trust from a "hold" rating to a "sell" rating in a research note on Thursday, March 27th. Two analysts have rated the stock with a sell rating and four have assigned a hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus price target of $17.00.

View Our Latest Stock Report on Healthcare Realty Trust

Healthcare Realty Trust Trading Down 1.5 %

HR stock traded down $0.24 during trading on Tuesday, reaching $15.39. 3,681,557 shares of the stock were exchanged, compared to its average volume of 3,270,304. Healthcare Realty Trust Incorporated has a twelve month low of $14.07 and a twelve month high of $18.90. The company has a market capitalization of $5.40 billion, a P/E ratio of -8.65 and a beta of 0.85. The stock has a 50 day simple moving average of $16.29 and a 200-day simple moving average of $16.89.

Healthcare Realty Trust (NYSE:HR - Get Free Report) last posted its earnings results on Wednesday, February 19th. The real estate investment trust reported $0.40 EPS for the quarter, topping the consensus estimate of $0.39 by $0.01. The business had revenue of $309.77 million during the quarter, compared to the consensus estimate of $303.81 million. Healthcare Realty Trust had a negative return on equity of 11.20% and a negative net margin of 51.60%. Healthcare Realty Trust's revenue was down 6.3% on a year-over-year basis. During the same quarter last year, the company earned $0.39 EPS. Equities analysts predict that Healthcare Realty Trust Incorporated will post 1.59 EPS for the current year.

Healthcare Realty Trust Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 19th. Stockholders of record on Monday, March 3rd were issued a dividend of $0.31 per share. This represents a $1.24 annualized dividend and a dividend yield of 8.06%. The ex-dividend date of this dividend was Monday, March 3rd. Healthcare Realty Trust's payout ratio is -69.66%.

About Healthcare Realty Trust

(Free Report)

Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.

See Also

Institutional Ownership by Quarter for Healthcare Realty Trust (NYSE:HR)

Should You Invest $1,000 in Healthcare Realty Trust Right Now?

Before you consider Healthcare Realty Trust, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthcare Realty Trust wasn't on the list.

While Healthcare Realty Trust currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Stocks Offering Rare Generational Buying Opportunities
Make Your Money Work Harder: The Power of Dividend Investing
7 Cybersecurity Stocks Outperforming the Market Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines